Mollugin: A Comprehensive Review of Its Multifaceted Pharmacological Properties and Therapeutic Potential
The substantial interest in plant-based drugs or plant-derived phytocompounds drives researchers to conduct comprehensive investigations on their therapeutic properties. Mollugin, one of the major active constituents of <i>Rubia cardifolia</i>, has been well-studied for its pharmacological properties, demonstrating potent anti-inflammatory properties by suppressing the TAK-1-mediated activation of NF-κB/MAPK and enhancing the Nrf2/HO-1-mediated antioxidant response. It exhibits strong anticancer effects through ferroptosis via IGF2BP3/GPX4 pathways, induces mitochondrial apoptosis, and targets NF-κB, ERK, and PI3K/Akt/mTOR to suppress tumor progression. Mollugin also inhibits JAK2/STAT and PARP1 pathways, suppressing IL-1β expression via the modulation of ZFP91. Moreover, it regulates the MAPK/p38 pathway, promotes neuroprotection, and improves cognitive performance through GLP-1 receptor activation. Mollugin promotes osteogenesis by activating the BMP-2/Smad1/5/8 signaling pathway and downregulates MAPK, Akt, and GSK3β expression, leading to the inhibition of osteoclastogenesis. It overcomes multidrug resistance by downregulating MDR1/P-gp, CREB, NF-κB, and COX-2 through AMPK activation. Its antibacterial effect is mediated by strong binding to FUR, UDP, and IpxB proteins in <i>Enterobacter xiangfangensis</i>. Mollugin mitigates <i>Klebsiella pneumoniae</i> infection, suppresses adipogenesis without causing cytotoxicity, and protects endothelial cells via the BDNF/TrkB-Akt signaling pathway. Synthetic derivatives of mollugin, such as oxomollugin and azamollugin, have shown enhanced anticancer and anti-inflammatory effects by regulating EGFR, PKM2, TLR4/MyD88/IRAK/TRAF6, and NF-κB/IRF3 pathways with improved solubility and stability. Collectively, these findings emphasize the broad-spectrum activity of mollugin. This review provides a critical interpretation of the mechanistic pathways regulated by mollugin and its derivatives, emphasizing their pharmacological significance and exploring their potential for future translation as multitarget drug candidates.
Authors
- Shreesh Ojha (ORCID: https://orcid.org/0000-0001-7801-2966)
- Bushra Zia (ORCID: https://orcid.org/0000-0001-5564-2180)
- Sandeep B. Subramanya (ORCID: https://orcid.org/0000-0002-4802-500X)
- Charu Sharma (ORCID: https://orcid.org/0000-0002-1762-0463)
- Sandra Ross Olakkengil Shajan (ORCID: https://orcid.org/0009-0008-1467-2701)
Institutions
- United Arab Emirates University (AE)
Publication Details
- Journal
- International Journal of Molecular Sciences
- Published
- 2025-12-13
- DOI
- https://doi.org/10.3390/ijms262412003
- Primary Topic
- Morinda citrifolia extract uses
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Strong
- United Arab Emirates University